top of page
Copy of Vibrant IP.png

VIP-3586

Procedural Barrier Packaging System

Reengineering sterile packaging into a standalone infection control system that extends medical device protection beyond storage and into the procedure.

  • Extending medical device protection beyond storage and into the procedure.


    DMED has developed a packaging system for single-use medical devices that remains around the device during use, extending its protective role into the medical procedure.


    Conventional medical packaging is discarded when a device is prepared for use. Once the device is fully exposed, preventing contamination depends on complex protocols, environmental conditions, infrastructure, equipment and resources, planning, preparation time, user expertise and user vigilance.


    Practically, in many real-world care settings achieving ANTT infection control is difficult or impossible.


    Why should packaging protection end when the procedure begins?


    DMED transforms medical packaging from passive storage into a standalone procedural infection

    control system. The device can be used from within the protective barrier, with key parts exposed only

    when required.


    By integrating ANTT principles directly into the packaging, the technology is developed to reduce reliance on environmental conditions, additional equipment and resources, and user expertise.


    With applications across multiple single-use device categories, DMED offers manufacturers the opportunity to expand and differentiate existing product portfolios through proprietary packaging technology.


    Available for strategic licensing and commercial partnerships.

  • The IP and assets available for sale include:

  • Other Public Data Room Materials Available at VIP-3586  Public Data Room for Novel Medical Packaging IP:

    • Introductory Materials

    • Patents and Patent Applications

    • Patent File Histories

    • Patent Assignment and Ownership

    • Deck

    Additional Materials (available upon signing a mutual Non-Disclosure Agreement):

    • Due Diligence Review

  • For more information, please contact Charlette Hunter at Vibrant IP, LLC at charlette@vibrantip.com and 404-482-3652.

bottom of page